PLOS Digital Health (Oct 2023)

Going beyond the means: Exploring the role of bias from digital determinants of health in technologies.

  • Marie-Laure Charpignon,
  • Adrien Carrel,
  • Yihang Jiang,
  • Teddy Kwaga,
  • Beatriz Cantada,
  • Terry Hyslop,
  • Christopher E Cox,
  • Krista Haines,
  • Valencia Koomson,
  • Guillaume Dumas,
  • Michael Morley,
  • Jessilyn Dunn,
  • An-Kwok Ian Wong

DOI
https://doi.org/10.1371/journal.pdig.0000244
Journal volume & issue
Vol. 2, no. 10
p. e0000244

Abstract

Read online

BackgroundIn light of recent retrospective studies revealing evidence of disparities in access to medical technology and of bias in measurements, this narrative review assesses digital determinants of health (DDoH) in both technologies and medical formulae that demonstrate either evidence of bias or suboptimal performance, identifies potential mechanisms behind such bias, and proposes potential methods or avenues that can guide future efforts to address these disparities.ApproachMechanisms are broadly grouped into physical and biological biases (e.g., pulse oximetry, non-contact infrared thermometry [NCIT]), interaction of human factors and cultural practices (e.g., electroencephalography [EEG]), and interpretation bias (e.g, pulmonary function tests [PFT], optical coherence tomography [OCT], and Humphrey visual field [HVF] testing). This review scope specifically excludes technologies incorporating artificial intelligence and machine learning. For each technology, we identify both clinical and research recommendations.ConclusionsMany of the DDoH mechanisms encountered in medical technologies and formulae result in lower accuracy or lower validity when applied to patients outside the initial scope of development or validation. Our clinical recommendations caution clinical users in completely trusting result validity and suggest correlating with other measurement modalities robust to the DDoH mechanism (e.g., arterial blood gas for pulse oximetry, core temperatures for NCIT). Our research recommendations suggest not only increasing diversity in development and validation, but also awareness in the modalities of diversity required (e.g., skin pigmentation for pulse oximetry but skin pigmentation and sex/hormonal variation for NCIT). By increasing diversity that better reflects patients in all scenarios of use, we can mitigate DDoH mechanisms and increase trust and validity in clinical practice and research.